Novo Nordisk has plenty of challenges to consider in the nearest future, but when it comes to what is probably the most discussed issue for Danish companies these days – sexism and sexual harassment in the workplace – Denmark's largest company and its 16,500 Danish employees don't have a single case to work with.
"We don't share specific figures, but we can state that we generally don't experience cases on sexism or sexual harassment in Denmark, and that in recent years cases like these haven't been raised in Denmark through our ombudsman function and hotline," Senior Vice President P&O Business Partnering at Novo Nordisk Mille Borchorst tells MedWatch.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app